0000048966-24-000008.txt : 20240401 0000048966-24-000008.hdr.sgml : 20240401 20240401171348 ACCESSION NUMBER: 0000048966-24-000008 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240401 DATE AS OF CHANGE: 20240401 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Terns Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001831363 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39926 FILM NUMBER: 24810862 BUSINESS ADDRESS: STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-525-5535 EXT.101 MAIL ADDRESS: STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100 CITY: FOSTER CITY STATE: CA ZIP: 94404 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Vivo Capital Surplus Fund VIII, L.P. CENTRAL INDEX KEY: 0001628048 ORGANIZATION NAME: IRS NUMBER: 472520160 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 BUSINESS ADDRESS: STREET 1: 505 HAMILTON AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 650 688 0818 MAIL ADDRESS: STREET 1: 505 HAMILTON AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 144 1 primary_doc.xml 144 0001628048 XXXXXXXX LIVE 0001831363 Terns Pharmaceuticals, Inc. 001-39926 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101 Vivo Capital Surplus Fund VIII, L.P. Director Common Cowen and Company, LLC

599 Lexington Ave Floor 21 New York NY 10022

8832 66795.00 64651693 04/01/2024 Nasdaq Common 02/04/2021 IPO Allocation IPO Underwriter N 8832 02/06/2021 Cash Y 04/01/2024 09/29/2023 Jack Nielsen